Williams Rowland Acquisition (WRAC) Peer Comparison

$10.50

$-0.07 (-0.66%)

As on 29-Feb-2024 20:00EDT

Market cap

$88 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

262.5

P/B Ratio

5

Div. Yield

0 %

Edit

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Market cap ($ Mln)	88	--	36
Revenue ($ Mln)	--	0	0
Net Profit ($ Mln)	2.39	-2.41	-2.41
Net Margin (%)	108.05	-944.78	-114.42
RoE (%)	10.81	--	--
Price to Earnings	262.50	--	--
Price-To-Book	5.04	--	123.73

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Operating Revenue	0.00	0.25	0.25
Cost of Revenue	2.19	0.00	0.00
Gross Profit	-1.57	0.25	0.25
Operating Expenses	0.87	3.85	3.85
Operating Profit (EBIT)	-0.87	-1.33	-1.33
Other Income	2.21	0.00	1.85
Profit before Tax	3.41	-1.91	-1.91
Provision for Tax	1.02	0.50	0.50
Profit after Tax (Net Income)	2.39	-2.41	-2.41
Minority Interest	0.00	0.00	0.00
Consolidated Profit	2.41	0.00	-2.93

Liabilities ($ Mln)

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Shareholder's Funds	17.37	-5.48	-5.48
Minority Interest	0.00	0.00	0.00
Non-Current Liabilities	8.05	9.15	9.15
Current Liabilities	2.01	4.80	4.80
Total Liabilities	36.60	42.37	42.37

Assets ($ Mln)

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Non-Current Assets	27.21	0.00	0.00
Current Assets	0.23	8.47	8.47
Total Assets	36.60	42.37	42.37
Total Debt*	1.33	1.40	1.40
Net Current Assets	-1.79	3.67	3.67

Cashflow ($ Mln)

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Cash From Operating Activities	-1.31	-1.09	-1.09
Cash Flow from Investing Activities	201.94	--	180.84
Cash from Financing Activities	-200.75	-138.70	-138.70
Net Cash Inflow / Outflow	-0.13	--	41.04

Ratios

Profitability Ratios

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
ROCE (%)	0.80	-0.77	-0.77
ROE (%)	10.81	-0.77	-0.77
ROA (%)	1.79	-2.47	-2.47
EBIT Margin (%)	--	-521.20	-521.20
Net Margin (%)	108.05	-944.78	-114.42
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Revenue Growth (%)	--	--	--
EBIT Growth (%)	169.58	100.00	100.00
Net Profit Growth (%)	514.17	-100.00	-100.00
EPS Growth (%)	460.22	--	--
Book Value Growth (%)	-92.34	-111.67	--

Valuation Ratios

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Price / Earnings	58.99	-1.48	--
Price / Book Value	2.24	0.40	--
Dividend Yield (%)	--	--	--
EV/EBITDA	-15.58	-0.20	-0.03
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Debt to Equity	0.00	0.00	0.00
Short term debt to equity ratio	0.08	-0.25	-0.25
Current Ratio	0.11	1.76	1.76
Quick Ratio	0.11	1.76	1.76
Interest Coverage	2.79	-8.06	-8.06

Operating Efficiency Ratios

	Williams Rowland Acquisition (WRAC)	Phoenix Biotech Acquisition (PBAXW)	Phoenix Biotech Acquisition Corp (PBAX)
Debtors to sales (%)	--	0.00	0.00
Asset Turnover	0.00	0.00	0.00
Receivable days	--	--	--
Inventory Days	--	--	--
Payable days	127.50	--	--
Cash Conversion Cycle	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly